# Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia

> **NCT05870995** · PHASE2 · RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 100 (estimated)

## Conditions studied

- Refractory Leukemia

## Interventions

- **DRUG:** CALGE-VEN- RIC-conditioning

## Key facts

- **NCT ID:** NCT05870995
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05870995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05870995, "Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05870995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*